News | January 18, 2012

Baptist Cardiac and Vascular Institute Aligns With Top European University to Access Latest Device Technology

The University of Heidelburg

The University of Heidelburg

January 18, 2012 — Baptist Cardiac & Vascular Institute of Miami announced a partnership with the University of Heidelberg, one of the largest and most important centers for patient care, medical research and teaching in Europe, for hands-on access to the latest medical innovations.

"Our institute has set the agenda in South Florida for cardiac and vascular procedures and treatment, but a lot of medical innovations are happening outside the United States. Our affiliation with the University of Heidelberg will bring a new line of knowledge in clinical medicine and broaden our perspective about new developments in patient care," Barry T. Katzen, M.D., founder and medical director of the institute, said.

The relationship will benefit South Florida patients, granting access to the most advanced treatments available for cardiac and vascular systems performed by heart surgeons, interventional radiologists and vascular surgeons.

"In our regulatory environment, it takes three to four years for innovations to be approved here. Our doctors, by traveling to Heidelberg, will already have been involved in early-stage technology. Over time it will have significant implications in patient care," Katzen said.

Dittmar Bockler, M.D., medical director and chairman of the department for vascular and endovascular surgery at Heidelberg University Hospital, agrees the partnership will result in better care for patients in the United States and Germany.

"Whenever there is transatlantic collaboration, the shared knowledge results in new developments and refinements," Dr. Bockler said. "Baptist Cardiac & Vascular Institute is a leader in multidisciplinary care and has pioneered many procedures that are of great interest to European physicians."

Both organizations are renowned as groundbreakers in cardiovascular care, involved in dozens of clinical trials and sophisticated diagnostic, treatment and rehabilitation services. They share a goal of searching for the least invasive treatments, particularly important for an aging population. Teams of interventional radiologists, clinical and interventional cardiologists, cardiothoracic surgeons, vascular surgeons, electrophysiologists, and neuroradiologists work together to provide a spectrum of care ranging from wellness to the most complex endovascular and open surgical procedures for heart and circulatory problems.

Baptist Cardiac & Vascular Institute, established in 1987, is part of Baptist Health South Florida, the largest faith-based, not-for-profit healthcare organization in the region.

For more information: www.baptistheart.net

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init